{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:03:34Z","timestamp":1784189014700,"version":"3.55.0"},"reference-count":39,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: The Martini and Melamed criteria for diagnosing multiple primary lung cancers (MPLCs) have remained in use for half a century despite substantial changes in lung cancer epidemiology, risk factors, imaging technologies, and treatment approaches. Correspondingly, the landscape of MPLC has likely changed, necessitating revisions to their diagnostic guidelines. Research Question: What are the clinicopathologic profiles of modern-day MPLC patients, and can these features be used to identify a subset of patients classified as MPLC that may warrant additional investigation as intrapulmonary metastasis (IPM)? Study Design and Methods: We conducted a retrospective cohort study using electronic medical record data from patients who underwent multiple lung cancer resections at Mount Sinai Hospital. Patient demographics, tumor characteristics, and surgical treatments were compared with those reported in the original Martini and Melamed series. We then proposed a reclassification framework incorporating a CT-based assessment of synchronous versus metachronous tumors and contemporary clinicopathologic features documented in imaging and pathology reports. Results: Ninety-one patients underwent successive lung cancer resections. Among first nodules treated with surgical resection, 46% exhibited pathologic features suggestive of metastasis within the lung, including visceral pleural invasion (18%), vascular invasion (24%), lymphatic invasion (36%), and\/or lymph node positivity (3%). In contrast, among second nodules (second temporal surgery), 45% demonstrated ground-glass opacity (GGO) supportive of a diagnosis of MPLC. Using the original criteria, 83 patients (91%) were classified as having MPLC; this proportion decreased to 53 patients (58%) under the reclassification criteria. Regardless of the criteria applied, contemporary MPLCs were more likely to occur in older patients, women, those with adenocarcinoma histology, and treated with sublobar resections compared with MPLCs described in the Martini and Melamed era. Conclusions: MPLCs are increasingly recognized, and their clinical presentation has changed substantially over time. Modern imaging and pathologic assessment may be useful tools for diagnosing MPLCs, but this requires future validation. This has important implications for staging and treatment decision-making, as patients may be undertreated by not being offered multimodal treatments or over-treated with systemic therapy when surgery alone may be sufficient.<\/jats:p>","DOI":"10.3390\/cancers18142284","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:49:36Z","timestamp":1784184576000},"page":"2284","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiple Primary Lung Cancers in Surgical Patients: Revisiting Martini and Melamed 50 Years Later"],"prefix":"10.3390","volume":"18","author":[{"given":"Stephanie","family":"Tuminello","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"},{"name":"Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"},{"name":"Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Housman","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1924-7110","authenticated-orcid":false,"given":"Jayme","family":"Leschly","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1029-4800","authenticated-orcid":false,"given":"Jai","family":"Mehrotra-Varma","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Zegarelli","sequence":"additional","affiliation":[{"name":"Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishoy","family":"Yacoub","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Storm","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7913-2799","authenticated-orcid":false,"given":"Apichat","family":"Tantraworasin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Clinical Surgical Research Center, Clinical Epidemiology and Clinical Statistic Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Taioli","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"},{"name":"Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"},{"name":"Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja M.","family":"Flores","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-5223(19)40289-4","article-title":"Multiple Primary Lung Cancers","volume":"70","author":"Martini","year":"1975","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e2137508","DOI":"10.1001\/jamanetworkopen.2021.37508","article-title":"Association of Stage Shift and Population Mortality Among Patients With Non-Small Cell Lung Cancer","volume":"4","author":"Flores","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"103033","DOI":"10.1016\/j.eclinm.2024.103033","article-title":"Evolving Trends in Lung Cancer Risk Factors in the Ten Most Populous Countries: An Analysis of Data from the 2019 Global Burden of Disease Study","volume":"79","author":"Jani","year":"2025","journal-title":"eClinicalMedicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102693","DOI":"10.1016\/j.canep.2024.102693","article-title":"Global Burden of Lung Cancer in 2022 and Projections to 2050: Incidence and Mortality Estimates from GLOBOCAN","volume":"93","author":"Zhou","year":"2024","journal-title":"Cancer Epidemiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jtho.2023.11.013","article-title":"Perspective on Management of Low-Dose Computed Tomography Findings on Low-Dose Computed Tomography Examinations for Lung Cancer Screening. From the International Association for the Study of Lung Cancer Early Detection and Screening Committee","volume":"19","author":"Henschke","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.21037\/atm.2017.07.28","article-title":"Ground Glass Opacities Management in the Lung Cancer Screening Era","volume":"6","author":"Migliore","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/COC.0000000000000440","article-title":"Comparison of In-Hospital and Long-Term Outcomes of Sublobar Lung Cancer Surgery by VATS and Open Techniques","volume":"41","author":"Tuminello","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/JTO.0b013e3182582a79","article-title":"Stage I Lung Cancer Survivorship: Risk of Second Malignancies and Need for Individualized Care Plan","volume":"7","author":"Surapaneni","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/jnci\/90.18.1335","article-title":"Second Lung Cancers in Patients after Treatment for an Initial Lung Cancer","volume":"90","author":"Johnson","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S523","DOI":"10.21037\/jtd.2019.01.56","article-title":"Multiple Primary Lung Cancer: A Rising Challenge","volume":"11","author":"Chen","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1097\/PAS.0b013e3181b8cf03","article-title":"Comprehensive Histologic Assessment Helps to Differentiate Multiple Lung Primary Nonsmall Cell Carcinomas from Metastases","volume":"33","author":"Girard","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jtho.2016.01.025","article-title":"The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer","volume":"11","author":"Detterbeck","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jtho.2019.01.017","article-title":"Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors","volume":"14","author":"Barritault","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jtho.2024.11.016","article-title":"Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From the International Association for the Study of Lung Cancer Pathology Committee","volume":"20","author":"Chou","year":"2025","journal-title":"J. Thorac. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jmoldx.2018.02.007","article-title":"Added Value of 50-Gene Panel Sequencing to Distinguish Multiple Primary Lung Cancers from Pulmonary Metastases: A Systematic Investigation","volume":"20","author":"Roepman","year":"2018","journal-title":"J. Mol. Diagn. JMD"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40291-020-00471-w","article-title":"Clonal Origin Evaluated by Trunk and Branching Drivers and Prevalence of Mutations in Multiple Lung Tumor Nodules","volume":"24","author":"Rodriguez","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1111\/cas.13797","article-title":"Comparative Mutational Evaluation of Multiple Lung Cancers by Multiplex Oncogene Mutation Analysis","volume":"109","author":"Takahashi","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1158\/1078-0432.CCR-19-1700","article-title":"Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach","volume":"25","author":"Chang","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1200\/JCO.2014.56.7644","article-title":"Identification of Independent Primary Tumors and Intrapulmonary Metastases Using DNA Rearrangements in Non-Small-Cell Lung Cancer","volume":"32","author":"Murphy","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"31133","DOI":"10.18632\/oncotarget.16096","article-title":"Mutational Analysis of Multiple Lung Cancers: Discrimination between Primary and Metastatic Lung Cancers by Genomic Profile","volume":"8","author":"Goto","year":"2017","journal-title":"Oncotarget"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tranon.2017.02.009","article-title":"Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis","volume":"10","author":"Saab","year":"2017","journal-title":"Transl. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13200","DOI":"10.1038\/ncomms13200","article-title":"Genomic Heterogeneity of Multiple Synchronous Lung Cancer","volume":"7","author":"Liu","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.21037\/jtd.2017.01.48","article-title":"Say Goodbye to Martini and Melamed: Genomic Classification of Multiple Synchronous Lung Cancer","volume":"9","author":"Stiles","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"a026617","DOI":"10.1101\/cshperspect.a026617","article-title":"Treatment-Induced Mutagenesis and Selective Pressures Sculpt Cancer Evolution","volume":"7","author":"Venkatesan","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jval.2021.09.017","article-title":"Cost-Effectiveness of Tumor Genomic Profiling to Guide First-Line Targeted Therapy Selection in Patients with Metastatic Lung Adenocarcinoma","volume":"25","author":"Dong","year":"2022","journal-title":"Value Health"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/jnci\/djae225","article-title":"Racial and Socioeconomic Disparities in Non\u2013Small Cell Lung Cancer Molecular Diagnostics Uptake","volume":"117","author":"Tuminello","year":"2025","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1148\/rg.272065061","article-title":"Nodular Ground-Glass Opacity at Thin-Section CT: Histologic Correlation and Evaluation of Change at Follow-Up","volume":"27","author":"Park","year":"2007","journal-title":"RadioGraphics"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Li, X., Ren, F., Wang, S., He, Z., Song, Z., Chen, J., and Xu, S. (2020). The Epidemiology of Ground Glass Opacity Lung Adenocarcinoma: A Network-Based Cumulative Meta-Analysis. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01059"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1183\/09031936.00047908","article-title":"Differential Diagnosis and Management of Focal Ground-Glass Opacities","volume":"33","author":"Infante","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/jcp.45.7.591","article-title":"Vascular Invasion in Non-Small Cell Lung Carcinoma","volume":"45","author":"Roberts","year":"1992","journal-title":"J. Clin. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/JTO.0b013e3182519a42","article-title":"Lymphovascular Invasion in Non-Small-Cell Lung Cancer: Implications for Staging and Adjuvant Therapy","volume":"7","author":"Higgins","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jss.2013.05.104","article-title":"Prognostic Impact of Lymphovascular Invasion Compared with That of Visceral Pleural Invasion in Patients with pN0 Non-Small-Cell Lung Cancer and a Tumor Diameter of 2 cm or Smaller","volume":"185","author":"Tao","year":"2013","journal-title":"J. Surg. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.athoracsur.2013.11.002","article-title":"Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis","volume":"97","author":"Mollberg","year":"2014","journal-title":"Ann. Thorac. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/jamaoncol.2024.2491","article-title":"Recurrence of Non\u2013Small Cell Lung Cancer With Visceral Pleural Invasion: A Secondary Analysis of a Randomized Clinical Trial","volume":"10","author":"Altorki","year":"2024","journal-title":"JAMA Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/01243894-200602000-00004","article-title":"Significance of the Number of Positive Lymph Nodes in Resected Non-Small Cell Lung Cancer","volume":"1","author":"Fukui","year":"2006","journal-title":"J. Thorac. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/JTO.0b013e31824cbad8","article-title":"Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non-Small-Cell Lung Cancer","volume":"7","author":"Hung","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"The National Lung Screening Trial Research Team (2013). Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer. N. Engl. J. Med., 368, 1980\u20131991.","DOI":"10.1056\/NEJMoa1209120"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/sam.11236","article-title":"Survival Analysis with Electronic Health Record Data: Experiments with Chronic Kidney Disease","volume":"7","author":"Hagar","year":"2014","journal-title":"Stat. Anal. Data Min."},{"key":"ref_39","unstructured":"(2025, May 16). Real-World Data and the Case of the Missing Deaths. Available online: https:\/\/resources.flatiron.com\/real-world-evidence\/real-world-data-missing-mortality."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/14\/2284\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:07:30Z","timestamp":1784185650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/14\/2284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":39,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["cancers18142284"],"URL":"https:\/\/doi.org\/10.3390\/cancers18142284","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]}}}